Darglitazone
Darglitazone (CP-86325) is a potent and selective PPAR-γ agonist used in research for its antidiabetic properties. It has demonstrated efficacy in modulating glucose and lipid metabolism in both in vitro assays and in vivo animal models of type 2 diabetes and insulin resistance.
Product Specifications
CAS Number
141200-24-0
Product Name Alternative
Inhibitor, oral, inhibit, Diabetes, CP 86325, CP86325, CP-86325, Darglitazone, corticosterone, UCP2, thiazolidinedione, PPAR, PPARγ, PPAR-γ, Peroxisome proliferator-activated receptors
Field of Research
Metabolism Research, Molecular Biology
Purity
99.19% (May vary between batches)
Solubility
10% DMSO+90% Corn Oil:2.5 mg/mL (5.95 mM) ; Ethanol:≤ 5 mg/mL; DMSO:55 mg/mL (130.8 mM)
Smiles
C (CC (=O) C1=CC=C (CC2SC (=O) NC2=O) C=C1) C=3N=C (OC3C) C4=CC=CC=C4
Molecular Formula
C23H20N2O4S
Molecular Weight
420.48
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TMAC-00976-01 50 μL
Anti-Phospho-c-Rel (Ser503) Polyclonal Antibody 2
Sign In for Pricing
View Details TMAC-00976-02 100 µL
Anti-Phospho-c-Rel (Ser503) Polyclonal Antibody 2
Sign In for Pricing
View Details 
GTR15099265 1 Vial
Lentiviral human NQO1 shRNA (UAS) - Lentiviral human NQO1 shRNA (UAS, RFP) plasmid
Sign In for Pricing
View Details 